Today: 3 July 2026
Browse Category

NASDAQ:PPCB 11 June 2026

Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

Propanc Biopharma, Inc. shares jumped Thursday as the company set a $5 million stock buyback plan. Investors saw the buyback as a vote of confidence from management for the beaten-down Nasdaq name. PPCB was last seen at $6.04, up $4.69 from Wednesday’s $1.35 close, after hitting $6.64 earlier on strong volume. PPCB’s story flipped after the announcement. On Wednesday, shares were stuck near the low end of the post-reverse-split range. By Thursday morning, traders had to factor in a buyback authorization that stands out for a company with only about 2.28 million post-split shares outstanding, based on May’s reverse-split disclosure.
11 June 2026
·

Stock Market Today

  • AtkinsRéalis Jumps C$683 Million as Turkey Looks at CANDU Nuclear Reactors
    July 3, 2026, 2:33 PM EDT. AtkinsRéalis Group Inc. (TSE:ATRL) stock rose 4.81% to C$91.87, lifting its market value by around C$683 million on July 3, 2026. The move beat the S&P/TSX Composite's 0.87% gain. Shares moved after news that Turkey started an initial review of AtkinsRéalis's CANDU small modular nuclear reactor design. Investors reacted even though the company has yet to sign a contract. The equity increase is about 93% of what the company's nuclear segment brought in for Q1, or C$736.6 million revenue. State-operated TUNAS is going through AtkinsRéalis's information and is expected to issue a report this summer, which could lead to nuclear project talks. Market cap stands at C$14.88 billion, with a Q1 backlog of more than C$20 billion.
Go toTop